Elevated Bone Mineral Density

Case Description:

There is no International Society for Clinical Densitometry consensus on the definition of elevated bone mineral density. A paper by Dr. Michael Whyte (below in references) suggested that a Z-score >= 2.5 as a diagnostic criterion for elevated bone mineral density. Elevated bone mineral density has a wide differential diagnosis. No further work-up was available to evaluate a cause of elevated bone mineral density in this patient. There are elevated Z-scores at the lumbar spine and both sites in the left proximal femur.

Credit:

Sarah L Morgan, MD, RD, CCD, The University of Alabama at Birmingham.

References:

• Schwartz, J.B. and M. Rackson, Diffuse idiopathic skeletal hyperostosis causes artificially elevated lumbar bone mineral density measured by dual X-ray absorptiometry. J Clin Densitom, 2001. 4(4): p. 385-8.
• Blake, G.M. and I. Fogelman, Effect of bone strontium on BMD measurements. J Clin Densitom, 2007. 10(1): p. 34-8.
• Blake, G.M. and I. Fogelman, The correction of BMD measurements for bone strontium content. J Clin Densitom, 2007. 10(3): p. 259-65.
• Blake, G.M., et al., A review of strontium ranelate and its effect on DXA scans. J Clin Densitom, 2007. 10(2): p. 113-9.
• Kurland, E.S., et al., Recovery from skeletal fluorosis (an enigmatic, American case). J Bone Miner Res, 2007. 22(1): p. 163-70.
• Liao, J., et al., The effect of bone strontium on BMD is different for different manufacturers’ DXA Systems. Bone, 2010. 47(5): p. 882-7.
• Tamer, M.N., et al., Osteosclerosis due to endemic fluorosis. Sci Total Environ, 2007. 373(1): p. 43-8
• Whyte, M.P., Misinterpretation of osteodensitometry with high bone density: BMD Z > or = + 2.5 is not “normal”. J Clin Densitom, 2005. 8(1): p. 1-6.
• Bagur, A., V. Dobrovsky, and C. Mautalen, Bone densitometry of a patient with osteosclerosis. J Clin Densitom, 2003. 6(1): p. 67-71.
• Balseiro, J., D.F. Eggli, and H.A. Ziessman, Paget’s disease. A cause of artificially elevated bone mineral density. Clin Nucl Med, 1987. 12(10): p. 809-10.
• De Luna, G., et al., High bone mineral density in sickle cell disease: Prevalence and characteristics. Bone, 2018. 110: p. 199-203.
• Gregson, C.L., et al., Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management. Rheumatology (Oxford), 2013. 52(6): p. 968-85.
• Gregson, C.L., et al., ‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass. Osteoporos Int, 2012. 23(2): p. 643-54.
• Hardcastle, S.A., et al., High bone mass is associated with an increased prevalence of joint replacement: a case-control study. Rheumatology (Oxford), 2013. 52(6): p. 1042-51.
• Balemans, W., et al., Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet, 2001. 10(5): p. 537-43.
• Bénichou, O.D., J.D. Laredo, and M.C. de Vernejoul, Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients. Bone, 2000. 26(1): p. 87-93.
• de Vernejoul, M.C., Sclerosing bone disorders. Best Pract Res Clin Rheumatol, 2008. 22(1): p. 71-83.
• Fosmoe, R.J., R.S. Holm, and R.C. Hildreth, Van Buchem’s disease (hyperostosis corticalis generalisata familiaris). A case report. Radiology, 1968. 90(4): p. 771-4.
• Fiore, C.E., et al., Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system. Osteoporos Int, 2005. 16(12): p. 2180-4.